These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31437740)

  • 1. Development of a brief clinician-reported outcome measure of multiple sclerosis signs and symptoms: The Clinician Rating of Multiple Sclerosis (CRoMS).
    Matza LS; Stewart KD; Phillips G; Delio P; Naismith RT
    Mult Scler Relat Disord; 2019 Oct; 35():253-261. PubMed ID: 31437740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mixed methods approach towards understanding key disease characteristics associated with the progression from RRMS to SPMS: Physicians' and patients' views.
    Ziemssen T; Tolley C; Bennett B; Kilgariff S; Jones E; Pike J; Tomic D; Piani-Meier D; Lahoz R
    Mult Scler Relat Disord; 2020 Feb; 38():101861. PubMed ID: 31865132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis: Results from a Contingent Valuation Study.
    Lin PJ; Saret CJ; Neumann PJ; Sandberg EA; Cohen JT
    Pharmacoeconomics; 2016 Dec; 34(12):1255-1265. PubMed ID: 27461538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Chalder Fatigue Questionnaire is a valid and reliable measure of perceived fatigue severity in multiple sclerosis.
    Chilcot J; Norton S; Kelly ME; Moss-Morris R
    Mult Scler; 2016 Apr; 22(5):677-84. PubMed ID: 26232100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of the FSIQ-RMS: A New Patient-Reported Questionnaire to Assess Symptoms and Impacts of Fatigue in Relapsing Multiple Sclerosis.
    Hudgens S; Schüler R; Stokes J; Eremenco S; Hunsche E; Leist TP
    Value Health; 2019 Apr; 22(4):453-466. PubMed ID: 30975397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensory nerve stimulation causes an immediate improvement in motor function of persons with multiple sclerosis: A pilot study.
    Almuklass AM; Capobianco RA; Feeney DF; Alvarez E; Enoka RM
    Mult Scler Relat Disord; 2020 Feb; 38():101508. PubMed ID: 31715503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force.
    Powers JH; Patrick DL; Walton MK; Marquis P; Cano S; Hobart J; Isaac M; Vamvakas S; Slagle A; Molsen E; Burke LB
    Value Health; 2017 Jan; 20(1):2-14. PubMed ID: 28212963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative Assessment of the Symptoms and Impact of Pancreatic Exocrine Insufficiency (PEI) to Inform the Development of a Patient-Reported Outcome (PRO) Instrument.
    Johnson CD; Arbuckle R; Bonner N; Connett G; Dominguez-Munoz E; Levy P; Staab D; Williamson N; Lerch MM
    Patient; 2017 Oct; 10(5):615-628. PubMed ID: 28332032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88).
    Hobart JC; Riazi A; Thompson AJ; Styles IM; Ingram W; Vickery PJ; Warner M; Fox PJ; Zajicek JP
    Brain; 2006 Jan; 129(Pt 1):224-34. PubMed ID: 16280352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SymptoMScreen: A Tool for Rapid Assessment of Symptom Severity in MS Across Multiple Domains.
    Green R; Kalina J; Ford R; Pandey K; Kister I
    Appl Neuropsychol Adult; 2017; 24(2):183-189. PubMed ID: 27077687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Vulvodynia Experience Questionnaire: Qualitative Development of a New Patient-Reported Outcome Measure for Vulvodynia.
    Goldstein AT; Diez PMQ; Kapanadze S; Cala ML; Evans CJ; Whyte JL; Christoph A
    J Sex Med; 2020 Oct; 17(10):2055-2066. PubMed ID: 32900670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis relapse: Qualitative findings from clinician and patient interviews.
    Matza LS; Kim K; Phillips G; Zorn K; Chan KS; Smith KC; Mowry EM
    Mult Scler Relat Disord; 2019 Jan; 27():139-146. PubMed ID: 30384199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six minutes of walking leads to reduced lower limb strength and increased postural sway in people with Multiple Sclerosis.
    McLoughlin JV; Barr CJ; Crotty M; Sturnieks DL; Lord SR
    NeuroRehabilitation; 2014; 35(3):503-8. PubMed ID: 25248444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata.
    Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Nunes FP; Dutronc Y; Mesinkovska N; Ko JM; King BA
    Am J Clin Dermatol; 2020 Oct; 21(5):725-732. PubMed ID: 32803546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postural Control Complexity and Fatigue in Minimally Affected Individuals with Multiple Sclerosis.
    Santinelli FB; Barbieri FA; Pinheiro CF; Amado AC; Sebastião E; van Emmerik REA
    J Mot Behav; 2019; 51(5):551-560. PubMed ID: 30689523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dorsiflexion assist orthosis reduces the physiological cost and mitigates deterioration in strength and balance associated with walking in people with multiple sclerosis.
    McLoughlin JV; Lord SR; Barr CJ; Crotty M; Sturnieks DL
    Arch Phys Med Rehabil; 2015 Feb; 96(2):226-232.e1. PubMed ID: 25264109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of balance-specific exercises on balance, physical activity and quality of life in adults with multiple sclerosis: a pilot investigation.
    Kasser SL; Jacobs JV; Ford M; Tourville TW
    Disabil Rehabil; 2015; 37(24):2238-49. PubMed ID: 25738911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in multiple sclerosis care: Results from an international mixed-methods study.
    Péloquin S; Schmierer K; Leist TP; Oh J; Murray S; Lazure P
    Mult Scler Relat Disord; 2021 May; 50():102854. PubMed ID: 33690086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Content Validation of Clinician-Reported Items for a Severity Measure for CDKL5 Deficiency Disorder.
    Saldaris J; Weisenberg J; Pestana-Knight E; Marsh ED; Suter B; Rajaraman R; Heidary G; Olson HE; Devinsky O; Price D; Jacoby P; Leonard H; Benke TA; Demarest S; Downs J
    J Child Neurol; 2021 Oct; 36(11):998-1006. PubMed ID: 34378447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple Sclerosis Outcome Assessments Consortium: Genesis and initial project plan.
    Rudick RA; Larocca N; Hudson LD;
    Mult Scler; 2014 Jan; 20(1):12-7. PubMed ID: 24057430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.